ResMed Current Ratio 2010-2025 | RMD

Current and historical current ratio for ResMed (RMD) from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. ResMed current ratio for the three months ending March 31, 2025 was 3.41.
ResMed Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2025-03-31 $3.21B $0.94B 3.41
2024-12-31 $2.84B $0.85B 3.33
2024-09-30 $2.64B $0.90B 2.92
2024-06-30 $2.36B $0.91B 2.59
2024-03-31 $2.35B $0.77B 3.04
2023-12-31 $2.38B $0.76B 3.11
2023-09-30 $2.31B $0.77B 2.99
2023-06-30 $2.37B $0.76B 3.12
2023-03-31 $2.34B $0.76B 3.07
2022-12-31 $2.33B $0.73B 3.17
2022-09-30 $2.03B $0.69B 2.94
2022-06-30 $1.93B $0.69B 2.80
2022-03-31 $1.70B $0.67B 2.55
2021-12-31 $1.55B $0.62B 2.49
2021-09-30 $1.59B $0.62B 2.54
2021-06-30 $1.58B $0.91B 1.73
2021-03-31 $1.47B $0.88B 1.67
2020-12-31 $1.45B $0.58B 2.51
2020-09-30 $1.54B $0.59B 2.61
2020-06-30 $1.52B $0.60B 2.53
2020-03-31 $1.47B $0.55B 2.67
2019-12-31 $1.30B $0.50B 2.60
2019-09-30 $1.16B $0.55B 2.11
2019-06-30 $1.15B $0.56B 2.06
2019-03-31 $1.10B $0.46B 2.38
2018-12-31 $1.06B $0.44B 2.44
2018-09-30 $1.09B $0.42B 2.58
2018-06-30 $1.07B $0.51B 2.09
2018-03-31 $1.60B $0.46B 3.48
2017-12-31 $1.75B $1.36B 1.29
2017-09-30 $1.66B $0.35B 4.72
2017-06-30 $1.64B $0.36B 4.57
2017-03-31 $1.61B $0.34B 4.77
2016-12-31 $1.52B $0.68B 2.23
2016-09-30 $1.48B $0.62B 2.38
2016-06-30 $1.42B $0.64B 2.23
2016-03-31 $1.40B $0.29B 4.89
2015-12-31 $1.35B $0.27B 5.09
2015-09-30 $1.53B $0.26B 5.96
2015-06-30 $1.41B $0.27B 5.28
2015-03-31 $1.55B $0.26B 6.06
2014-12-31 $1.56B $0.26B 6.00
2014-09-30 $1.54B $0.25B 6.04
2014-06-30 $1.56B $0.27B 5.77
2014-03-31 $1.56B $0.25B 6.33
2013-12-31 $1.56B $0.24B 6.44
2013-09-30 $1.56B $0.61B 2.55
2013-06-30 $1.45B $0.57B 2.52
2013-03-31 $1.58B $0.58B 2.72
2012-12-31 $1.53B $0.25B 6.09
2012-09-30 $1.45B $0.25B 5.73
2012-06-30 $1.36B $0.25B 5.38
2012-03-31 $1.33B $0.26B 5.15
2011-12-31 $1.25B $0.23B 5.46
2011-09-30 $1.14B $0.23B 5.06
2011-06-30 $1.29B $0.21B 6.19
2011-03-31 $1.20B $0.19B 6.28
2010-12-31 $1.15B $0.25B 4.64
2010-09-30 $1.07B $0.29B 3.73
2010-06-30 $0.99B $0.31B 3.15
2010-03-31 $1.03B $0.33B 3.17
2009-12-31 $0.93B $0.24B 3.86
2009-09-30 $0.94B $0.29B 3.22
2009-06-30 $0.85B $0.27B 3.17
2009-03-31 $0.73B $0.23B 3.19
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $40.718B $4.685B
ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $222.716B 26.12
Boston Scientific (BSX) United States $157.517B 37.62
Stryker (SYK) United States $152.893B 31.97
EssilorLuxottica (ESLOY) France $140.240B 0.00
Medtronic (MDT) Ireland $118.558B 16.81
Lonza Group Ag (LZAGY) Switzerland $50.586B 0.00
Haleon (HLN) United Kingdom $44.070B 25.15
GE HealthCare Technologies (GEHC) United States $35.587B 16.90
Agilent Technologies (A) United States $34.042B 22.19
Koninklijke Philips (PHG) Netherlands $26.981B 17.85
Terumo (TRUMY) Japan $25.673B 33.35
Insulet (PODD) United States $20.514B 80.52
Zimmer Biomet Holdings (ZBH) United States $18.786B 12.06
Baxter (BAX) United States $14.800B 11.05
Smith & Nephew SNATS (SNN) United Kingdom $13.840B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $6.874B 23.92
Lantheus Holdings (LNTH) United States $4.995B 12.60
Perrigo (PRGO) Ireland $3.859B 9.78
Prestige Consumer Healthcare (PBH) United States $3.689B 16.48
Haemonetics (HAE) United States $3.629B 16.53
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.441B 28.59
ICU Medical (ICUI) United States $3.119B 23.00
LeMaitre Vascular (LMAT) United States $1.863B 41.64
QuidelOrtho (QDEL) United States $1.720B 11.83
AtriCure (ATRC) United States $1.571B 0.00
Acuren (TIC) United States $1.369B 0.00
Green Thumb Industries (GTBIF) United States $1.272B 28.62
AdaptHealth (AHCO) United States $1.259B 12.78
Phibro Animal Health (PAHC) United States $1.135B 14.51
BioLife Solutions (BLFS) United States $1.057B 0.00
Neogen (NEOG) United States $1.048B 16.66
Curaleaf Holdings (CURLF) Canada $0.933B 0.00
InMode (INMD) Israel $0.905B 9.11
Kestra Medical Technologies (KMTS) United States $0.847B 0.00
Valneva SE (VALN) France $0.660B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.632B 0.00
Evolus (EOLS) United States $0.596B 0.00
Tilray Brands (TLRY) Canada $0.581B 0.00
Owens & Minor (OMI) United States $0.576B 4.78
Surmodics (SRDX) United States $0.535B 0.00
CeriBell (CBLL) United States $0.533B 0.00
ZimVie (ZIMV) United States $0.524B 23.81
SNDL (SNDL) Canada $0.384B 0.00
VAREX IMAGING (VREX) United States $0.322B 11.83
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Capricor Therapeutics (CAPR) United States $0.308B 0.00
Quanterix (QTRX) United States $0.304B 0.00
Sanuwave Health (SNWV) United States $0.298B 0.00
Cresco Labs (CRLBF) United States $0.295B 0.00
Cerus (CERS) United States $0.254B 0.00
Aurora Cannabis (ACB) Canada $0.250B 74.00
Biote (BTMD) United States $0.249B 7.00
Viemed Healthcare (VMD) United States $0.247B 20.87
Omeros (OMER) United States $0.245B 0.00
OraSure Technologies (OSUR) United States $0.245B 0.00
Brainsway (BWAY) Israel $0.224B 59.15
Sanara MedTech (SMTI) United States $0.222B 0.00
Verano Holdings (VRNOF) United States $0.217B 0.00
Canopy Growth (CGC) Canada $0.209B 0.00
Organigram Global (OGI) Canada $0.189B 0.00
Utah Medical Products (UTMD) United States $0.183B 15.09
Exagen (XGN) United States $0.180B 0.00
Vireo Growth (VREOF) United States $0.177B 0.00
High Tide (HITI) Canada $0.175B 0.00
TriSalus Life Sciences (TLSI) United States $0.164B 0.00
TerrAscend (TSNDF) Canada $0.132B 0.00
FitLife Brands (FTLF) United States $0.123B 15.18
Jushi Holdings (JUSHF) United States $0.107B 0.00
Jin Medical (ZJYL) China $0.100B 0.00
MacroGenics (MGNX) United States $0.100B 0.00
Fonar (FONR) United States $0.099B 12.74
Quipt Home Medical (QIPT) United States $0.095B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.090B 0.00
Safety Shot (SHOT) United States $0.081B 0.00
Zynex (ZYXI) United States $0.075B 0.00
Apyx Medical (APYX) United States $0.074B 0.00
Veru (VERU) United States $0.072B 0.00
InterCure (INCR) Israel $0.068B 0.00
Agape ATP (ATPC) $0.064B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Cytosorbents (CTSO) United States $0.057B 0.00
Modular Medical (MODD) United States $0.038B 0.00
United-Guardian (UG) United States $0.037B 12.92
Nephros (NEPH) United States $0.037B 49.57
Rockwell Medical (RMTI) United States $0.035B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
INLIF (INLF) $0.016B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Senestech (SNES) United States $0.012B 0.00
IM Cannabis (IMCC) Canada $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00